REPL · Forms 3, 4, 5
Insider trades at Replimune Group, Inc.
4 insiders sold $1M of Replimune Group, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Replimune Group, Inc. (REPL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Philip Astley-Sparke | Director | Gift | 50,000 | Form 4 | |||
| Emily Luisa Hill | Chief Financial Officer | Sell | 9,256 | $14.28 | $132K | Form 4 | |
| BAKER BROS. ADVISORS LP | Director | Options or other derivatives | Form 4 | ||||
| Sushil Patel | Chief Executive Officer | Sell | 39,341 | $12.97 | $510K | Form 4 | |
| Emily Luisa Hill | Chief Financial Officer | Sell | 11,448 | $12.97 | $148K | Form 4 | |
| Konstantinos Xynos | Chief Medical Officer | Sell | 11,447 | $12.97 | $148K | Form 4 | |
| Andrew Schwendenman | Chief Accounting Officer | Sell | 7,632 | $12.97 | $99K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.